Opportunity
SAM #75N98026Q00543
NIH NCI Procurement of Agilent xCELLigence RTCA MP Real-Time Cell Analyzer
Buyer
NIH Office of Logistics and Acquisition Operations
Posted
June 07, 2026
Respond By
June 17, 2026
Identifier
75N98026Q00543
NAICS
334516
The National Institutes of Health (NIH), through the National Cancer Institute (NCI) CCR Genomics Core, is seeking to procure a specialized cell analysis system to support advanced cancer research. - Government Buyer: - National Institutes of Health (NIH) - National Cancer Institute (NCI) - CCR Genomics Core, under Dr. Liz Conner - OEM Highlight: - Agilent is the sole Original Equipment Manufacturer (OEM) specified - Product Requested: - Agilent xCELLigence RTCA MP system - Part number: Agilent xCELLigence RTCA MP - Quantity: 1 unit - Description: Real-time cell analyzer for non-invasive, label-free, impedance-based monitoring of cell health, behavior, and function over periods ranging from seconds to days - Purpose and Unique Requirements: - Supports translational research for cell-based cancer therapies, including CAR and TCR therapies, antibody-drug conjugates (ADCs), and small-molecule agents - Enables development of potency assays relevant to FDA-approved CAR T therapies - System must provide real-time, label-free, and non-invasive monitoring capabilities - No additional products, services, or vendors are mentioned in the available documentation
Description
Attachment: Notice of Intent